ClinVar Miner

Submissions for variant NM_001036.6(RYR3):c.4533G>C (p.Glu1511Asp)

gnomAD frequency: 0.00001  dbSNP: rs772574630
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000685782 SCV000813279 uncertain significance Epileptic encephalopathy 2020-03-04 criteria provided, single submitter clinical testing This variant is present in population databases (rs772574630, ExAC 0.005%). This variant has not been reported in the literature in individuals with RYR3-related conditions. ClinVar contains an entry for this variant (Variation ID: 566062). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C35"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces glutamic acid with aspartic acid at codon 1511 of the RYR3 protein (p.Glu1511Asp). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and aspartic acid.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.